Implications for Medical Affairs Teams in 2024 and Beyond
In 2024, medical affairs teams are pivotal in driving strategic impact within the pharmaceutical industry. They [...]
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.
Vertex Pharmaceuticals Acquires Alpine Immune Sciences for $4.9 Billion
Vertex Pharmaceuticals is set to acquire Alpine Immune Sciences for $4.9 billion, expanding its portfolio into [...]
Sanofi to Close Kiadis Division Amid Pipeline Prioritization
Sanofi has decided to shut down Kiadis, a natural killer (NK) cell company acquired for $357 [...]
Congressional Concerns Over BGI’s Alleged Ties to Chinese Military
US lawmakers have raised alarms about BGI, a major Chinese genomics firm, allegedly attempting to skirt [...]
Bristol Myers Squibb Announces Layoffs at Mirati Therapeutics Following Acquisition
Bristol Myers Squibb (BMS) has initiated a significant workforce reduction at the headquarters of the recently [...]
Lenz Therapeutics Opts for Reverse Merger Ahead of Phase 3 Results
Lenz Therapeutics made its Nasdaq debut through a reverse merger, a strategic choice that CEO Eef [...]
AstraZeneca Acquires Fusion Pharmaceuticals for $2 Billion
AstraZeneca has announced a $2 billion acquisition of Fusion Pharmaceuticals, significantly investing in the burgeoning field [...]
Boundless Bio Eyes Nasdaq with Innovative Cancer Treatment Approach
Boundless Bio, a San Diego-based biotech startup, has announced its intention to go public on the [...]
Pfizer’s Strategic Oncology Expansion Post-Seagen Acquisition
Pfizer aims to bolster its oncology portfolio by targeting at least eight cancer blockbuster drugs by [...]
UK Intensifies Childhood Vaccination Efforts Amid Measles Outbreak
The UK is confronting an escalating measles outbreak by launching an advertising campaign to encourage childhood [...]
Johnson & Johnson Shuts Down Brisbane R&D Center Amid Strategic Shift
Johnson & Johnson (J&J) is closing its nearly 200,000 square-foot research and development (R&D) outpost in [...]
Rick Gonzalez’s Legacy and AbbVie’s Future under Robert Michael
Rick Gonzalez, CEO of AbbVie, transformed Humira into the world's top-selling drug, defying politics and competition. [...]
MAPS Americas 2024
Now is a time of sea change in the biopharmaceutical and MedTech industries as we move toward a more patient-centric [...]
5th Next-Gen MSL Excellence
The MSL role may never fully return to what it was before COVID, as it is now commonplace for KOLs to [...]
3rd Diversity in Clinical Trials
There has never been a greater time or need than now for pharma to move the needle on making clinical [...]
8th Digital Strategy & Innovation for Medical Affairs
DGE’s 8TH Digital Strategy & Innovation for Medical Affairs Summit is the largest and most impactful industry event for transforming [...]
4th KOL & Advanced Practice Providers Forum
KOLs and APPs can be the driving force behind therapeutic success if effectively selected and managed by company stakeholders. Modern [...]
Joshua Boger Takes Chair at CervoMed, Eyes Potential Breakthrough in Dementia Treatment with Neflamapimod
Joshua Boger, the former CEO of Vertex Pharmaceuticals, has selectively accepted a new role as chair [...]
Emerging Biotechs Lead 2024’s Most Anticipated Drug Launches
The key points and takeaways from the report on the most anticipated new drugs of 2024 [...]
Saudi Arabia Launches National Biotech Strategy to Establish Global Leadership by 2030
Saudi Arabia has initiated a national biotech strategy as part of its Vision 2030 project, aiming [...]
Healthcare Innovations and Economic Opportunities Highlighted at 2024 J.P. Morgan Healthcare Conference
The 2024 J.P. Morgan Healthcare Conference in San Francisco drew a large attendance, showcasing emerging trends [...]
Natera Acquires Invitae’s Reproductive Health Assets Amid Cost-Cutting Measures
Natera has acquired Invitae’s reproductive health assets, including noninvasive prenatal and carrier screening tests, for $10 [...]
Biotech Industry Updates: Major Ventures, Partnerships, and Corporate Changes
Jennifer Doudna's Latest Venture: Doudna's lab published a study in Nature Biotechnology about using antibody fragments [...]
Challenges in Removing B/Yamagata Component from Global Flu Vaccines Amid Regulatory Complexities
In response to the disappearance of the B/Yamagata strain of flu B virus during the COVID-19 [...]
